Clinical Trials Directory

Trials / Completed

CompletedNCT00521508

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Role of CD4+CD25+FoxP3+ Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Along structural IgA abnormalities, hyperproduction of IgA is thought to play a role in the pathogenesis of primary IgA nephropathy. CD4+CD25+Fox3P regulatory T cells are instrumental in suppressing adaptative immune responses, including B cells production of immunoglobulins. We, the researchers at Centre Hospitalier Universitaire de Saine Etienne, will test the hypothesis that IgA production in patients with IgA nephropathy is dysregulated because of a quantitative and/or qualitative defect of CD4+CD25+FoxP3+ regulatory T cells.

Conditions

Interventions

TypeNameDescription
PROCEDUREgene transcription and cytometrysamply of 30 ml of blood

Timeline

Start date
2008-04-01
Primary completion
2010-04-01
Completion
2010-09-01
First posted
2007-08-28
Last updated
2010-09-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00521508. Inclusion in this directory is not an endorsement.